Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/EVOKE PHARMA INC/ EFFECT

SEC Filing · EFFECT

EVOKE PHARMA INC

EVOKOTCEQUITYCurrent

SEC Filing

Filed Dec 18, 2025Accepted Dec 18, 2025, 7:15 PM ESTCIK 1403708Accession 9999999995-25-003821
View company →Permanent SEC source ↗
Share

Company context

Current securities

EVOKOTC · EQUITY · Current

Recent company filings

  1. 15-12G filingDec 30, 2025
  2. SCHEDULE 13D/A - filed by Nantahala Capital Management, LLC regarding Evoke Pharma IncDec 19, 2025
  3. EFFECT filingDec 18, 2025
  4. EFFECT filingDec 18, 2025
  5. EFFECT filingDec 18, 2025

As-filed source

Primary evidence
As filedOpen full document ↗